Epizyme, Inc.
Hydrochloride salt form for EZH2 inhibition
Last updated:
Abstract:
Provided herein are novel solid forms of N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl (tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-bip- henyl]-3-carboxamide hydrochloride, and related compositions and methods.
Status:
Grant
Type:
Utility
Filling date:
5 Jun 2018
Issue date:
14 Jul 2020